Chronic Kidney Disease Trial, Recruiting NCT06257134 Sponsor: Central Hospital, Nancy, France Condition: Chronic Kidney Disease
Back to Chronic Kidney Disease

Chronic Kidney Disease Trial, Recruiting

NCT06257134
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For patients:

  • Adults aged 18 or older who have been fully informed about the study and have not objected to taking part or to their data being used
  • People with end-stage kidney disease (kidney failure) who are receiving dialysis at one of the clinics taking part in the study
  • People who are able to answer questionnaires

For healthcare professionals (a separate part of the study):

  • Doctors and nurses working in a dialysis unit that is taking part in the study who have been fully informed and have not objected to their participation or the use of their data

Who may not be able to join:

For patients:

  • People under the age of 18
  • People who are under a legal protection order, guardianship, or similar supervised legal arrangement
  • People who are unable to communicate or are unable to give consent to participate
  • People receiving dialysis at a unit that is not part of the study
  • People receiving dialysis temporarily at a participating unit, such as for short-term or holiday care
  • People with cognitive difficulties that affect their thinking or understanding
  • People who are unable or unwilling to complete questionnaires

For healthcare professionals:

  • Healthcare professionals who do not wish to participate voluntarily
  • Healthcare professionals who do not work at a facility taking part in the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Francis GUILLEMIN, MD, PhD, Centre d'Investigation Clinique - Epidémiologie Clinique 1433

Phone: 03 83 15 35 39

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
6 February 2026
Est. completion
15 September 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Health-related quality of life over 12 months, measured by the physical health score of the validated Kidney Disease and Quality of Life™ Short Form (KDQoL-36) questionnaire.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov